Zhejiang Jingxin Pharmaceutical (002020.SZ) plans to spend 200 million to 400 million yuan to implement a share buyback. The repurchase price will not exceed 14.8 yuan per share.

08/01/2025

GMT Eight

Zhejiang Jingxin Pharmaceutical (002020.SZ) announced that the company plans to use its own funds to repurchase company shares through centralized bidding trading. The repurchased shares will be used for equity incentives or employee stock ownership plans. The total amount of the repurchase will be no less than RMB 200 million (including) and no more than RMB 400 million (including), with a repurchase price not exceeding RMB 14.8 per share (including). The implementation period of the share repurchase will be within 12 months from the date of approval by the board of directors of the repurchase plan.

ZOOMLION (01157) spent approximately 12.0366 million Hong Kong dollars to repurchase 2.2162 million shares on January 8th.

Sinopec SSC (01033) spent 3.9131 million yuan to repurchase 2 million A-shares on January 8th.

Contact: contact@gmteight.com

Zhejiang Jingxin Pharmaceutical (002020.SZ) plans to spend 200 million to 400 million yuan to implement a share buyback. The repurchase price will not exceed 14.8 yuan per share.

RECOMMEND

HK Stock Market Move | AINNOVATION (02121) opened more than 3% higher. The industrial large model "AInnoGC" by the intelligent strategist Kong Ming has been filed with the National Internet Information Office.

Financial consolidation of Ping An Group, the synergistic effect is expected to continue to manifest in the future.

Hong Kong stock concept tracking | Seamless transition of old-for-new policy Institutional optimism on the consumption potential of the home appliance industry chain (including concept stocks)